Fig. 6
From: Preclinical comparison of prolgolimab, pembrolizumab and nivolumab
Antitumor effect of pembrolizumab and prolgolimab in vivo. The graphs shows the change in the average (A) or individual (B, C, D) volume of tumors in groups of animals relative to the start time of treatment administration. Error bars—95% confidence interval for mean tumor size. Statistical analyses were performed using the Tukey’s multiple comparisons test. The inset shows tumor growth inhibition index (TGI) data for day 17.
